This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT04810078
Brief Title: A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread (CheckMate-67T)

First Submitted : March 16, 2021
First Submitted that Met QC Criteria : March 19, 2021
First Posted : March 22, 2021

Last Update Submitted that Met QC Criteria : October 11, 2023
Last Update Posted : October 12, 2023